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Abstract
Background: During mammalian protein N-glycosylation, 20% of all dolichol-linked oligosaccharides (LLO) appear as free
oligosaccharides (fOS) bearing the di-N-acetylchitobiose (fOSGN2), or a single N-acetylglucosamine (fOSGN), moiety at their
reducing termini. After sequential trimming by cytosolic endo b-N-acetylglucosaminidase (ENGase) and Man2c1
mannosidase, cytosolic fOS are transported into lysosomes. Why mammalian cells generate such large quantities of fOS
remains unexplored, but fOSGN2 could be liberated from LLO by oligosaccharyltransferase, or from glycoproteins by
NGLY1-encoded Peptide-N-Glycanase (PNGase). Also, in addition to converting fOSGN2 to fOSGN, the ENGASE-encoded
cytosolic ENGase of poorly defined function could potentially deglycosylate glycoproteins. Here, the roles of Ngly1p and
Engase1p during fOS metabolism were investigated in HepG2 cells.
Methods/Principal Findings: During metabolic radiolabeling and chase incubations, RNAi-mediated Engase1p down
regulation delays fOSGN2-to-fOSGN conversion, and it is shown that Engase1p and Man2c1p are necessary for efficient
clearance of cytosolic fOS into lysosomes. Saccharomyces cerevisiae does not possess ENGase activity and expression of
human Engase1p in the png1D deletion mutant, in which fOS are reduced by over 98%, partially restored fOS generation. In
metabolically radiolabeled HepG2 cells evidence was obtained for a small but significant Engase1p-mediated generation of
fOS in 1 h chase but not 30 min pulse incubations. Ngly1p down regulation revealed an Ngly1p-independent fOSGN2 pool
comprising mainly Man8GlcNAc2, corresponding to ,70% of total fOS, and an Ngly1p-dependent fOSGN2 pool enriched in
Glc1Man9GlcNAc2 and Man9GlcNAc2 that corresponds to ,30% of total fOS.
Conclusions/Significance: As the generation of the bulk of fOS is unaffected by co-down regulation of Ngly1p and
Engase1p, alternative quantitatively important mechanisms must underlie the liberation of these fOS from either LLO or
glycoproteins during protein N-glycosylation. The fully mannosylated structures that occur in the Ngly1p-dependent
fOSGN2 pool indicate an ERAD process that does not require N-glycan trimming.
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Introduction
During protein N-glycosylation, oligosaccharyltransferase (OST)
transfers the oligosaccharide Glc3Man9GlcNAc2 from the mature
lipid linked oligosaccharide precursor (LLO, Glc3Man9GlcNAc2-
PP-dolichol) onto asparagine residues in the consensus sequence
Asn-X-Ser/Thr of nascent proteins [1]. N-linked oligosaccharides
play crucial roles in the quality control, folding, ER-associated
degradation (ERAD) and subcellular trafficking of glycoproteins
[2]. During both mammalian LLO biosynthesis and ERAD, free
oligosaccharides (fOS) possessing the di-N-acetylchitobiose moiety
at their reducing end (fOSGN2), are generated [3,4]. Evidence
suggests that, in vitro, fOSGN2 can be released from LLO by OST
[5,6,7], or from misfolded glycoproteins by cytosolic peptide N-
glycanase (PNGase) [8]. Accordingly characterising fOS produc-
tion in cells reveals insights into key regulatory points in protein N-
glycosylation and quality control.
In mammalian cells fOSGN2 are transported out of the ER into
the cytosol [9,10], and subsequently, after cytosolic trimming [11]
are transported into lysosomes [12] to be degraded. Cytosolic
trimming of fOSGN2 is accomplished by an endo-b-N-acetylglu-
cosaminidase (ENGase, [13]) or chitobiase [14] to yield fOS
bearing a single N-acetylglucosamine (GlcNAc) residue at their
reducing termini (fOSGN). These structures are the preferred
substrates for the cytosolic mannosidase [15], encoded by the
MAN2C1 gene [16,17], that trims Man9GlcNAc to generate
(Mana1-2Mana1-2Mana1-3(Mana1-6)Manb1-4GlcNAc: linear
isomer of Man5GlcNAc) that is transported into lysosomes [12].
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disposal of fOS has been proposed [18,19], many aspects of fOS
metabolism remain to be elucidated. First, in mammalian cells
grown under normal culture conditions up to 20% of all
oligosaccharides synthesized as LLO appear as fOS during or
rapidly after glycoprotein biosynthesis, but presently the propor-
tion of fOS that are generated from glycoproteins during ERAD
or from LLO is unknown. In S. cerevisiae the PNG1-encoded
cytosolic PNGase [20] generates greater than 70% of all fOSGN2
[3,21]. By contrast to the situation in yeast, there are no data
concerning the importance of Ngly1p [22], the mammalian
ortholog of Png1p, during mammalian fOS generation. Second,
although S. cerevisiae does not possess ENGase activity and all fOS
in this organism are generated as fOSGN2, several studies using
mammalian cells report circumstantial evidence suggesting that
fOSGN may be released directly from glycoproteins by an
ENGase [5,23,24,25]. Furthermore, the cytosolic ENGase encod-
ed by the C. elegans [26], chicken [27] and human [28] ENGASE
gene is capable of generating fOSGN from glycoproteins as well as
converting fOSGN2 to fOSGN in vitro. However, the in vivo roles of
mammalian Engase1p [28], during fOS metabolism have yet to be
addressed.
Here, we have used RNA interference (RNAi) and pharmaco-
logical approaches to knock down Ngly1p and Engase1p activities
in order to gain insight into the mechanisms underlying fOS
release in the HepG2 cell line. We have characterised and
quantitated Ngly1p-dependent and -independent fOSGN2 pools.
It is shown that hEngase1p is able to deglycosylate misfolded
glycoproteins in an S. cerevisiae png1D strain and evidence was
obtained for a deglycosylating function for this enzyme in HepG2
cells. Results demonstrate that Engase1p plays a major role in the
clearance of cytosolic fOS into lysosomes. Finally, it is shown that
in HepG2 cells a major fraction of fOS is not generated by either
Ngly1p or Engase1p.
Materials and Methods
Reagents
HepG2 cells were obtained from ATCC (Rockville, MD). D-
mannitol and D-sorbitol were from Fluka (St Quentin Fallavier,
France). D-[2-
3H]mannose (20 Ci/mmole) and En
3hance spray
were purchased from PerkinElmer Life Sciences (Zaventem, BE).
Thin Layer Chromatography (TLC) plates were obtained from
MERCK (Darmstadt, DE). AG 50-X2 (H
+ form) and AG 1-X2
(acetate form) came from Biorad S.A. (Marnes la Coquette, FR).
Streptolysin O (SLO) was a generous gift from Sucharit Bhakdi
(Institute of Medical Microbiology and Hygiene, Mainz, DE).
Concanamycin A (CCMA) was a gift from Dr. J.R. Green (Ciba-
Geigy, Ltd, CH). Swainsonine (SW), 2-aminopyridine, N-benzoyl-
L-tyrosine-p-nitroanilide, dimethylformamide, lyticase, reduced
glutathione, p-nitrophenyl-a-D-glucopyranoside, fucose, sodium
cyanoborohydride, Triton 6100, protease inhibitor cocktails,
endo-b-N-acetylglucosaminidase from Streptococcus plicatus (EndoH),
brefeldin A (BFA), 3-methyladenine, Kodak X-OMAT AR film
and pronase were purchased from SIGMA–Aldrich SARL (St
Quentin Fallavier, FR). Methyl a-D-mannopyranoside, methyl-a-
D-glucopyranoside and castanospermine (CST) were from Tor-
onto Research Chemicals Inc. (Toronto, CA). Stealth small
interfering RNA (siRNA) duplexes, stealth RNAi negative medium
and low GC control duplex, reduced serum medium (Opti-MEM
I), Lipofectamine RNAiMAX, and the Superscript
TM Preampli-
fication System were from Invitrogen (Cergy Pontoise, FR).
RNeasy Mini Kit, RNase-free DNase I, the anti-His Antibody
Selector Kit and the 6xHis Protein Ladder were obtained from
Qiagen (Courtaboeuf, FR). ABsolute Blue QPCR SYBR Green
Mix and BCA
TM Protein Assay kit were purchased from Thermo
Scientific (Courtaboeuf, FR). Yeast minimal SD base medium and
minimal SD agar base were purchased from Ozyme (Saint-
Quentin-en-Yvelines, FR). The yeast strain BY4742 and Y12156
were obtained from Euroscarf (Frankfurt, DE). The lactate
dehydrogenase (LDH) detection cytotoxicity kit was purchased
from Roche Diagnostics (Meylan, FR). Z-vad-fmk was from
Promega (Charbonnie `res-les-Bains, FR).
Cell Culture and transfection
HepG2 cells were routinely cultivated in RPMI 1640 supple-
mented with 10% foetal calf serum (FCS) and 1% penicillin/
streptomycin and were maintained at 37uC in a humidified
atmosphere with 5% CO2. Sequences of Stealth siRNA duplexes
used for specific down regulation of the ENGASE, MAN2C1 and
NGLY1 mRNA are listed in Table S1. According to their GC
content, medium GC or low GC Stealth RNAi duplexes were used
as negative control. All siRNA duplexes were transiently
transfected into HepG2 cells by using Lipofectamine RNAiMax
according to the protocol of the manufacturer.
mRNA expression analysis
Total RNA was isolated from transfected HepG2 cells using the
RNeasy Mini Kit using an RNase-free DNase I step according to
the instructions of the manufacturer. The quality of the total RNA
was assessed after agarose gel electrophoresis. First strand cDNA
was synthesized from 2.5 mg of total RNA employing the
Invitrogen Superscript
TM Preamplification System and an oli-
go(dT)12-18 primer as reverse primer. The sequences of the primers
used for PCR, real time PCR or sequencing are listed in Table S1.
Real time quantification of transcripts was performed using a
CHROMO IV Detector (MJ Research, Boston MA) with SYBR
Green PCR master mix. All specific primer couples used for real
time quantitative PCR (QPCR) were designed to cover exonic
sequences separated by large intronic regions. The results of each
gene were normalized with the Ct value of b2 microglobulin
(b2M) or S14.
Radiolabeling and permeabilization of cells
48 h after transfection in 6 well plates, cells were pulse-
radiolabeled with 20 mCi [2-
3H]mannose in 500 ml of glucose-free
RPMI 1640 medium supplemented with 2% dialyzed FCS,
0.5 mM glucose and 2 mM fucose. For chase conditions, cells
were incubated in 1 ml of pre-warmed complete RPMI 1640
medium supplemented with 2 mM fucose; after the indicated
chase time, the medium was removed and cells were cooled to 4uC
and washed twice with ice cold PBS. Cells were permeabilized
with SLO as described previously [11]: cells were incubated at 4uC
with 0.5 ml of a pre-cooled permeabilization buffer (5 mM Hepes,
pH 7.0, containing 250 mM mannitol and 2 mM CaCl2)
containing 2 mg/ml of SLO. After 1 h of incubation, the SLO-
containing medium was removed from the cells and combined
with a subsequent wash of 1 ml permeabilization buffer.
Recovery of fOS, glycoproteins and LLO from
radiolabeled cells
These procedures have been described previously [11,29].
Briefly the cell layer was scraped into 4 ml of MeOH/100 mM
Tris HCl (pH 7.4) containing 4 mM MgCl2, 2:1. An equal volume
of CHCl3 was added and the mixture vigorously shaken. After
centrifugation, the lower (CHCl3) and upper (methanolic) phases
were removed. Neutral fOS were recovered from the upper
Free Oligosaccharide Control
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CHCl3 phase and from CHCl3/MeOH/H2O 10:10:3 extracts of
the interphase proteins. Oligosacharides were released from LLO
after mild acid hydrolysis with 0.02N HCl, 30 min at 100uC.
Glycoproteins (GP) from the 10:10:3-extracted protein pellet and
the TCA-precipitated glycoproteins recovered from cell culture
medium were submitted to pronase digestion to yield glycopep-
tides. Oligosaccharides were released from glycopeptides using
EndoH. Recovery of unlabelled fOS from yeast cells, their
derivatisation with the fluorophore 2-aminopyridine, and analysis
by HPLC will be described elsewhere (Chantret, I. et al.,
manuscript in preparation).
Analytical procedures
Glycopeptides were analysed by concanavalin A (ConA)-
Sepharose chromatography as described previously [30]. Sepa-
ration of fOSGN2 and fOSGN was achieved after derivatisation
of oligosaccharide mixtures with 2-aminopyridine (AP) as
previously reported [31,32]. All oligosaccharide-AP derivatives
are positively charged but only fOSGN2-AP are cleaved after
digestion with EndoH, and after AG-50 ion exchange chroma-
tography are recovered as fOSGN in the water wash. The ion-
exchange resin is then washed with 0.2 M NH4OH in order to
elute fOSGN-AP. Oligosaccharides and oligosaccharide-AP
derivatives were resolved by thin-layer chromatography (TLC)
on silica-coated plastic sheets (0.2 mm thickness) in n-propanol/
acetic acid/water, 3/3/2 for 16–24h. Radioactive components
were detected on X-OMAT AR film by fluorography after
spraying the dried TLC plates with En
3hance and were
quantitated by scintillation counting after their elution with
water from the silica. Where indicated, fOS mixtures and fOS-AP
mixtures were resolved by HPLC using an amine-bonded silica
column (LiChrospher Amino 5 mm, 250 mm64.6 mm, Sulpelco
Inc). Two eluents were used: eluent A (90% acetonitrile, 10%
30 mM triethylamine acetate, pH 7.3, buffer) and B (10%
acetonitrile, 90% 30 mM triethylamine acetate, pH 7.3, buffer).
The column was equilibrated in 85% A and 15% B, and after
sample injection, was subjected to a linear solvent gradient
developed over 80 min until the final solvent mixture of 68% of A
and 32% of B was obtained. Radiolabeled oligosaccharides were
detected by a Packard 150 TR flow-scintillation analyser and
oligosaccharide-AP derivatives were quantitated using a Jasco FP-
2020 Plus fluorescence detector (excitation wavelength 310 nm,
emission wavelength 380 nm).
Yeast strains, plasmid construction, transformation and
culture
Saccharomyces cerevisiae strains used in this study are: BY4742
(MATa; his3D1; leu2D0; lys2D0; ura3D0), Y12156 (MATa; his3D1;
leu2D0; lys2D0; ura3D0; png1::kanMX4), ams1D (MATa; am-
s1::HIST3MX6; leu2D0; lys2D0; ura3D0) and ams1Dpng1D (MATa;
ams1::HIST3MX6; leu2D0; lys2D0; ura3D0; png1::kanMX4). The
last two strains were derived from BY4742 and Y12156
respectively and were generated by homologous recombination
[33] using the PCR product generated with the template pFA6a-
His3MX6 plasmid kindly provided by M. S. Longtine (Oklahoma
State University, USA). Yeast were transformed using lithium
acetate, and transformants were isolated after growth on solid
selective medium (lacking histidine). The correct replacement of
the target gene by the auxotrophic His3MX6 marker, was
confirmed by PCR amplification. A plasmid encoding His6-
tagged Engase1p was kindly provided by T. Suzuki (RIKEN
Advanced Science Institute, JP). The coding region of human
ENGASE was amplified by PCR: the his6-tag sequence was
added in-frame immediately before the stop codon. After
digestion with XbaI and SalI, the PCR product was subcloned
into the URA3 pRS416-GPD plasmid. The correct sequence of
the insert was verified by DNA sequencing. Yeasts were
transformed as above with either the plasmid construct or the
empty vector. Culture of transformants was performed in liquid
selective medium (lacking uracil).
Yeast subcellular fractionation and enzyme assays
Cells were harvested by centrifugation and washed with distilled
water at room temperature. The pellet was then resuspended in
1 ml of buffer A (50 mM Tris/HCl pH 8, 1.5 M sorbitol, 2 mM
MgCl2,6 0m Mb-mercaptoethanol). After 10 min of preincuba-
tion at 30uC, cells were converted to spheroplasts by adding
lyticase (10 units/OD600nm yeast) and incubating 15 min under
gentle shaking at 30uC. Spheroplasts were loaded onto a cushion
of 500 ml of buffer B (50 mM Tris/HCl pH 8, 1.8 M sorbitol,
2 mM MgCl2) in an Eppendorf tube kept on ice. After
centrifugation for 5 min at 6000 gAv at 4uC, the pellet is carefully
resuspended in buffer A. After repeating this procedure twice, the
pellet is resuspended in buffer C (20 mM K
+/Pipes, pH 6.8,
100 mM sorbitol, 100 mM KCl, 50 mM K
+/acetate, 5 mM
magnesium acetate) and spheroplast permeabilization based on
differential osmotic lysis was performed as previously described
[34] for 30 min on ice. After centrifugation for 10 min at
20,000 gAv, the supernatant containing cytosol, and the pellet
were separated and the membrane fraction was homogenized in
buffer C. Yeast a-glucosidase (aGlc) [35] and Carboxypeptidase Y
(CPY) [36] were measured as previously described. For ENGase
assay, [2-
3H]-mannose labeled polymannose-type glycopeptides
were incubated overnight at 37uC in the presence of aliquots of
subcellular fractions derived from mock transformed or hEnga-
se1p-expressing yeast. The reactions were heated for 5 min at
100uC prior to centrifugation for 5 min at 10000 gAv. The
supernatant was loaded on AG-1/AG-50 column. The effluent
and water washes contain neutral oligosaccharides which were
quantitated by scintillation counting. Background radioactivity
observed for fractions derived from mock transformed yeast were
subtracted from that observed in fractions from the hEngase1p
expressing strain.
For SDS-PAGE, yeast cells were harvested at mid-log growth,
washed, and after adding the same volume of glass beads, were
extracted with lysis buffer (50 mM Tris/HCl, pH 8.0, 2 mM
PMSF supplemented with protease inhibitors). The cells were
disrupted via three sequential 60 s burst on a Vortex mixer
followed by cooling on ice for 60 s. After 5 min heating at 95uC,
the resulting supernatant was cleared by centrifugation at
10000 gAv for 10 min. SDS-PAGE was followed by immunoblot-
ting with the tetra-His antibody.
Results
Experimental strategy
Potentially both Ngly1p and Engase1p could give rise to fOS in
mammalian cells and could have overlapping functions. Accord-
ingly, inhibition of one enzyme may lead to compensatory activity
by the other leading to difficulty in ascertaining the normal roles of
these enzymes. Thus our strategy was to look at the effects of
inhibiting the enzymes either separately or together. We started
with down regulating Engase1p as this enzyme is potentially
involved in both glycoprotein deglycosylation and in the
conversion of fOSGN2 to fOSGN. The ability to block this latter
reaction would greatly facilitate interpretation of experiments
where the role of Ngly1p in generating fOSGN2 is evaluated.
Free Oligosaccharide Control
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fOSGN conversion in HepG2 cells
Two human EST sequences possibly derived by alternative
splicing of the cytosolic ENGase gene (ENGASE) have been
reported: one encodes a protein of 377 amino acids whose function
is unknown (Gene bank accession FLJ21865) and the other
encodes a 743 amino acid protein (Engase1p) possessing
glycopeptide hydrolysing activity in vitro (Gene bank accession
AJ397822, [28]). Using cDNA generated from HepG2 cell RNA,
we could amplify the latter but not the former transcript (data not
shown). Accordingly, 3 siRNA duplexes (ENG-1, ENG-2 and ENG-
3) targeting the transcript encoding the longer protein were
designed (Table S1). HepG2 cells were transiently transfected with
increasing quantities of either negative control or the ENGASE-
targeted siRNA duplexes, and ENGASE mRNA silencing was
evaluated by RT-QPCR. As demonstrated in Fig S1, these agents
inhibited ENGASE mRNA levels in a dose-dependent manner
and ENG-3 was the most efficient causing a 70% decrease of
ENGASE mRNA. To assess the consequence of this mRNA
silencing on fOS metabolism, HepG2 cells were radiolabeled with
[2-
3H]mannose for 30 min. All three siRNA duplexes induce a
concomitant reduction of incorporation of radiolabel into
[2-
3H]LLO, [2-
3H]glycoproteins and [2-
3H]fOS. But, when
[2-
3H]fOS is calculated as a percentage of total [2-
3H]mannose
incorporation into cells ([2-
3HLLO + [2-
3H]glycoproteins +
[2-
3H]fOS), ,15% total cell radioactivity was recovered as
[2-
3H]fOS in both ENGASE-targeted siRNA and control
transfected cells (Fig 1A). TLC analysis of fOS from pulse
radiolabeled control cells (Fig 1B, upper panel) reveals a mixture of
fOSGN2 and fOSGN comprising mainly Glc1-0Man9-8GlcNAc2
and Glc1-0Man9-8GlcNAc as previously described [11,32]. By
contrast, in HepG2 cells transfected with ENGASE-targeted
siRNA duplexes, there is a striking reduction of fOSGN (Fig 1B,
upper panel). The proportion of total [2-
3H]fOS occurring as
[2-
3H]fOSGN and [2-
3H]fOSGN2 was estimated after derivati-
zation of [2-
3H]fOS with 2-aminopyridine (2-AP, see Materials
and Methods). Using this data the incorporation of radiolabel into
fOSGN2 and fOSGN was calculated and expressed as a
percentage of total cellular incorporation of radiolabel (Fig 1C).
Under these conditions the 3 siRNA duplexes provoke ,75%
inhibition of the appearance of fOSGN (Fig 1C). TLC analysis of
the fOSGN and fOSGN-AP species demonstrated that, as
expected [32], both fOS populations included components
containing 8 or 9 residues of mannose and a monoglucosylated
species comprising 9 residues of mannose (Fig 1B, middle and
lower panels). The reduction of incorporation of radioactivity into
LLO, glycoproteins and fOS provoked by the 3 ENGASE-
targeted siRNA duplexes could be due to a general slowing down
of the glycosylation pathway leading to an apparent increase in the
ratio of fOSGN2 to fOSGN. To investigate this possibility pulse
radiolabeling was followed by 30 min and 1 h chase incubations in
the presence of complete growth medium. Data shown in Fig 1D
demonstrate that the rate of consumption of [
3H]LLO observed in
cells transfected with the 3 ENGASE-targeted siRNA duplexes is
not significantly reduced compared to the rate seen in cells
transfected with the control RNAi duplex. Furthermore, although
some variability was noted, the 3 ENGASE-targeted siRNA
duplexes did not have a systematic effect on the rate of
glycoprotein secretion from cells when compared to the secretion
observed from cells transfected with the control RNAi duplex
(Fig 1E). After 1 h chase incubations there are approximately
equal amounts of fOSGN2 and fOSGN in ENG-3-treated cells
whereas in control cells fOS comprise .95% fOSGN (Fig 1F).
Also, it was noted that even after a 1 h chase period in ENG-3-
treated cells, greater than 95% of all fOSGN2 occurred as
components co migrating with standard Glc1Man9GlcNAc2,M a n 9-
GlcNAc2,a n dM a n 8GlcNAc2 (Fig 1G). To summarize, down-
regulation of ENGASE expression delays clearance of fOSGN2 from
cells. In the experiments reported above we were unable to detect a
correlation between the efficacities of the three duplexes to inhibit
mRNA expression (Fig S1) and their abilities to block the appearance
of fOSGN (Fig 1C). Although we do not understand the origin of this
discrepency, it was noted that ENG-1 and ENG-2 led to the lowest
incorporation of[2-
3H]mannoseinto glycoconjugates. For thisreason
all further analysis was performed using ENG-3.
Engase1p trimming of fOSGN2 is required for normal fOS
trafficking in HepG2 cells
Previous results have indicated that prior to efficient transloca-
tion into lysosomes, cytosolic fOSGN are partially demannosylated
by a cytosolic mannosidase [11], which corresponds to the protein
encoded by the MAN2C1 gene [17]. It is known that this enzyme
acts more effectively on fOSGN substrates than their fOSGN2
counterparts [37]. As the results described in Fig 1 demonstrate
that Engase1p has an important role in the conversion of fOSGN2
to fOSGN, an experiment was performed in order to evaluate the
impact of this block on fOS trafficking in HepG2 cells and
compare this effect with that caused by down regulation of
Man2c1p. First, 3 MAN2C1-targeted siRNA duplexes (M2C1-1,
M2C1-2 and M2C1-3, Table S1) were tested, and 2–3 days after
transfection all three were found to decrease MAN2C1 transcript
levels by 75–80% without greatly affecting mRNA expression of
the Golgi Man2a1p and lysosomal Man2b1p a-mannosidases (Fig
S2A). Preliminary experiments in which cells were pulse
radiolabeled with [2-
3H]mannose for 30 min prior to a 4 h chase
incubation revealed that all 3 duplexes provoked a striking
inhibition of [2-
3H]fOSGN mannose trimming (Fig S2B) without
significantly affecting N-glycan trimming in the Golgi apparatus
(Fig S2C). Accordingly, cells were transfected with control,
ENGASE- (ENG-3), and MAN2C1- (M2C1-1) targeted siRNA
duplexes 2 days prior to performing pulse-chase experiments.
After 6 h chase incubations, the cells were permeabilised with
streptolysin O (SLO) as previously described to yield a cytosol
fraction containing cytoplasmic components including lactate
dehydrogenase (LDH), and a residual cellular fraction that has
been shown to contain intact lysosomes, Golgi apparatus, and ER
(Membrane bound compartments, MBC) [32]. Finally, in order to
better evaluate cytosol-to-lysosome translocation of fOS a second
series of pulse chase studies were performed in the presence of the
vacuolar ATPase inhibitor concanamycin A (CCMA). This agent
is known to inhibit the degradation of fOS after their translocation
into lysosomes [11] while at the same time blocking lysosomal
glycoprotein degradation thereby allowing analysis of fOS
metabolism without interference from oligosaccharides potentially
derived from the latter process. After 6 h of chase, control
incubations (Fig 2A, upper panel) yield low amounts of fOS in the
cytosol and MBC fractions, and only trace amounts of these
components can be detected in the culture medium (Med). By
contrast, in the presence of CCMA (Fig 2A, lower panel), striking
increases in the quantity of fOS containing 6 or less residues of
mannose are observed in the MBC and chase medium.
Radioactivity associated with fOS possessing more than 6 residues
of mannose and that associated with those possessing less than 7
residues of mannose was assayed in each compartment and
expressed as a percentage of radioactivity associated with total
cellular and medium fOS (Fig 2D). It can be seen that small fOS
recovered from the media of CCMA-treated cells accounts for less
than 10% of radioactivity associated with total fOS. ENG-3
Free Oligosaccharide Control
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and lower panels of Fig 2B with those of Fig 2A) and quantitation
of fOS that accumulate in the presence of CCMA (Fig 2D)
demonstrates that this agent reduces the appearance of smaller
fOS (, Man7GlcNAc) in both the MBC and cell medium.
Likewise, M2C1-1 causes a striking accumulation of large fOSGN
(. Man6GlcNAc) in the cytosol (compare upper and lower panels
of Fig 2C with those of Fig 2A), and a concomitant reduction in
smaller fOS (, Man7GlcNAc) in both the MBC and cell medium
(Fig 2D). Accordingly, down-regulation of Engase1p expression
slows down the conversion of fOSGN2 into fOSGN and, similarly
to down regulation of Man2c1p, reduces the rate at which small
fOSGN gain access to the lysosome and extracellular space.
Down regulation of ENGASE expression modifies the
steady state levels of fOS in both the cytosol and MBC of
HepG2 cells
A detailed analysis of the steady state levels of cytosolic fOS in
HepG2 cells has been reported, and although fOSGN2 were not
detected, a complex mixture of glucosylated and nonglucosylated
fOSGN was described [38]. In another report down-regulation of
Man2c1p using an siRNA strategy in HEK-293 cells caused an
accumulation of the substrates of this enzyme (Glc1-0Man9-7
GlcNAc) but little reduction in its limit digest product (Man5-
GlcNAc) steady state level, indicating an alternative, quantitatively
important, mechanism for the generation of this latter component
in these cells [17]. In order to further examine the consequences of
Engase1p down-regulation on fOS metabolism, fOS steady state
levels were examined in the cytosol and MBC of cells transfected
with ENG-3 and compared to fOS levels observed in cells
transfected with control and M2C1-1 siRNA duplexes. Total
fOS were extracted from the different compartments and
derivatised with 2-AP. The resulting fOS-AP derivatives were
then resolved by HPLC before and after digestion with EndoH:
only fOSGN2-AP are cleaved and loose their fluorescent tag. It
was observed that the EndoH treatment only modified fOS elution
profiles in a region of the chromatographs corresponding to the
elution times of Glc1Man9GlcNAc2-AP and Man9-7GlcNAc2-AP
standards, and this region of the elution profiles is shown in Fig 3A.
Differences in the superimposed HPLC profiles (2 EndoH/+
EndoH) as shown in Fig 3A for the cytosol fractions of control-
transfected (left panel) and ENG-3-transfected (right panel) cells
reveal the presence of only small quantities of fOSGN2 in control
cells and 6–11 fold increases in these components in ENG-3-
Figure 1. ENGASE mRNA silencing alters fOS metabolism. A.
Three days post transfection with 25 pmoles of control RNAi duplexes
(Ctrl) or ENGASE RNAi duplexes (ENG-1, ENG-2 and ENG-3), cells were
pulse-radiolabeled with [2-
3H]mannose for 30 min. Incorporation of
[2-
3H]mannose into LLO, Glycoproteins and fOS was measured and
summed to give total cellular radioactivity. The percentage of this total
occurring as [2-
3H]fOS was calculated. B. [2-
3H]fOS were resolved by TLC
(upper panel). After derivatisation with 2-aminopyridine, EndoH
digestion and fractionation of incubation mixtures on AG-50 ion-
exchange resin, [2-
3H]fOS were separated into [2-
3H]fOSGN (originally
fOSGN2) and [2-
3H]fOSGN-AP (originally fOSGN) before analysis by TLC.
The migration positions of standard oligosaccharides or oligosaccharide
AP-derivatives are shown to the left of the chromatographs. Closed and
open arrowheads indicate the migration positions of fOSGN and
fOSGN2 respectively. The abbreviations are: G1M9; Glc1Man9GlcNAc1-2,
M9; Man9GlcNAc1-2,M 8; Man8GlcNAc1-2. C. The percentage of total
radioactivity incorporated into LLO glycoproteins and fOS recovered as
[2-
3H]fOSGN was calculated. D-E. Cells transfected with either ENG-1,
ENG-2, ENG-3 or control RNAi duplexes were pulse radiolabeled for
30 min (t=0) and then chased in normal growth medium for 30 min
and 1 h. D. [
3H]LLO were recovered from the cells and quantitated by
scintillation counting. E. [
3H]glycoproteins were recovered from the
cells and incubation media and the percentage of total [
3H]glycopro-
teins (cells+medium) recovered from the media is reported. F-G. Cells
transfected with ENG-3 or control RNAi duplexes were pulse
radiolabeled for 30 min and then chased in normal growth medium
for 30 min and 1 h. F. After recovery of fOS, the amount of fOS
occurring as fOSGN2 was calculated as percentage of total fOS. G.
Examination of the fOSGN2 species by TLC. Although the effects of the
different RNAi duplexes were noted several times and found to be
reproducible, the detailed analyses shown in A,C, and D-G were
performed once.
doi:10.1371/journal.pone.0011734.g001
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the ENG-3-transfected cells appear to elute similarly to standard
Glc1Man9GlcNAc2-AP, Man9GlcNAc2-AP and Man8GlcNAc2-
AP. By contrast to the metabolic radiolabeling experiments shown
in Fig 1, small quantities of an oligosaccharide behaving as
Man7GlcNAc2-AP were also noted in the ENG-3-transfected cells
(Fig 3A, right panel). In addition, the HPLC profiles indicate that
the peak corresponding to Man8GlcNAc2-AP is not symmetrical
and comprises a shoulder on its leading edge indicating the
presence of a second component (Fig 3A, right panel). At present it
is not clear whether this second minor Man8GlcNAc2-AP
component and the Man7GlcNAc2-AP structure represent slow
processing of Glc1-0Man9-8GlcNAc2 oligosaccharides by cytosolic
mannosidase or whether they arise directly from either LLO or
glycoprotein. In cells transfected with M2C1-1, large quantities of
interfering fOSGN impeded unambiguous detection of fOSGN2
(results not shown). Finally, with the amount of starting material
used, fOSGN2 could not be clearly identified in MBC fractions.
Fig 3B shows the chromatographs obtained when the EndoH-
treated samples containing only fOSGN-AP were analysed. A
Figure 3. Effects of Engase1p and Man2c1p down regulation on steady-state levels of cytosolic and MBC fOS in HepG2 cells. fOS
recovered from both the cytosol and the MBC fractions of SLO-permeabilized, control siRNA (Control), ENG-3 or M2C1-1 -transfected cells, were
derivatized with 2-AP, and analyzed by HPLC before (2 EndoH) and after digestion with EndoH from S. plicatus (+ EndoH). A. HPLC profiles of the
cytosolic PA-derivatized fOS obtained before (Blue traces) and after EndoH (Red traces) digestion from control siRNA (Left panel) or ENG-3 (Right
panel) transfected HepG2 cells. The open arrowheads indicate the migration positions of fOSGN2-AP derivatives whose appearance is abrogated after
EndoH digestion. Only the region of the chromatograms that display significant differences before and after EndoH digestion is shown. B. The EndoH
treated fOS from the cytosol (Upper panel) and membrane bound compartments MBC (Lower panel) were resolved by HPLC and the migration
positions of standard radioactive oligosaccharide 2-AP derivatives are indicated, and where known, the isomeric configuration of the standard
structures are indicated (Green circles; mannose, blue squares; N-acetylglucosamine). The asteriks indicate peaks corresponding to oligosaccharides
whose abundance does not change under the different conditions. In both A and B the background noise associated with the ENG-3 profiles is higher
than in either the control or M2C1-3 traces because the fluorescence scale was amplified to take into account the smaller amount of cells recovered
from ENG-3 transfected cultures. This experiment was performed once, but a preliminary experiment, in which cells were not permeabilised with SLO,
was performed and found to give qualitatively similar results.
doi:10.1371/journal.pone.0011734.g003
Figure 2. Subcellular distribution of fOS in control and CCMA-treated cells after down regulation of Engase1p and Man2c1p. Three
days after cells were transiently transfected with either (A) control RNAi duplexes (Control) or (B) RNAi duplexes targeting ENGASE (ENG-3) or (C)
MAN2C1 (M2C1-1), cells were pulse-radiolabeled with [2-
3H]mannose, and submitted to 6 h chase incubations in the absence (A, B and C, upper
panels) or the presence of 10 nM CCMA (A, B and C, lower panels). Cells were then permeabilized with SLO as described in Material and Methods. fOS
purified from the cytosolic fraction (Cyt) and the membrane bound compartments (MBC) and from the chase media (Med) were resolved by TLC. TLC
plates were exposed to film for different numbers of days (Exp) in order to better visualise components whose abundances differ greatly between
conditions. The migration positions of standard oligosaccharides are shown to the left of the chromatographs and the abbreviations associated with
the open arrowheads are: M9, Man9GlcNAc2; M8, Man8GlcNAc2; the abbreviations associated with the closed arrowheads are: G1M9, GlcMan9GlcNAc;
M9, Man9GlcNAc; M8, Man8GlcNAc; M7, Man7GlcNAc; M6, Man6GlcNAc; G1M5, GlcMan5GlcNAc; and M5, Man5GlcNAc. D. Oligosaccharides were eluted
from the chromatograms corresponding to the fluorograms shown in the lower panels of A, B and C (+ CCMA) and quantitated by scintillation
counting. To simplify interpretation of results, radioactivity associated with oligosaccharides greater in size than Man6GlcNAc (. M6) was summed as
was that obtained for oligosaccharides smaller than Man7GlcNAc (, M7). The bars indicate the percentage of total fOS recovered from each
incubation. This experiment was performed once.
doi:10.1371/journal.pone.0011734.g002
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different siRNA duplexes is beyond the scope of the present
report, but two important observations can be underlined.
First, as well as their capacity to increase large cytosolic fOS
levels (Glc1-0Man9-7GlcNAc2 for ENG-3:F i g3 Aa n dG l c 1-
0Man9-7GlcNAc for M2C1-1: Fig 3B, green trace) ENG-3 and
M2C1-1 siRNA duplexes reduce the steady state concentration
of cytosolic Man5GlcNAc, and do so with a relative potency
that mirrors their ability to provoke the accumulation of
f O S G N 2a n du n t r i m m e df O S G N ,r e s p e c t i v e l y .S e c o n d ,d a t a
presented in Table 1 indicate that for large fOS, ,5–15% of
the total cellular amount (Cyt + MBC) of each component
is associated with the MBC, however this value increases to
50–90% for oligosaccharides that co migrate with standard
Man4-3GlcNAc. This observation is consistent with previous
results indicating a predominantly lysosomal localization of
fOSGN possessing less than 5 residues of mannose [11]. Results
presented in both Fig 3B and Table 1 demonstrate that in
addition to reducing levels of cytosolic Man5GlcNAc, both the
ENG-3 and M2C1-1 siRNA duplexes reduce the levels of Man4-
3GlcNAc that occur in the MBC. To summarize, the effects of
ENG-3 and M2C1-1 siRNA duplexes on steady state levels of
fOS in HepG2 cells are consistent with the hypothesis that
Engase1p and Man2c1p have a concerted action in regulating
the subcellular trafficking of fOS in HepG2 cells.
HepG2 cells express two alternatively spliced NGLY1
variants but the effect of Ngly1p on fOS generation is
attributable to the protein encoded by the longest
transcript
The preceeding results indicate that Engase1p has an important
role in conversion of fOSGN2 to fOSGN but only a minor, if any,
role in glycoprotein deglycosylation. Next, the role of the NGLY1-
encoded cytosolic PNGase in fOS generation was examined in
HepG2 cells. First, RNAi duplexes that effectively targeted NGLY1
expression were sought, but searches in silico indicated several EST
sequencespotentiallyarising fromalternative transcripts.Inorderto
detect these transcripts, primers were designed to span the regions
containing sequence differences but after RT-PCR, only the region
corresponding to the C-terminus of Ngly1p yielded different
amplified products. Indeed, using forward primer NGLY1-10long
and the reverse primer NGLY1-8 (Table S1), the major PCR
product (339 bp) expected of the published human NGLY1 mRNA
sequence [20] and a minor PCR product of 161 bp were detected.
Both PCR products were sequenced and found to correspond to the
transcripts shown in Fig 4A. The minor transcript was found to
correspond to the EST sequence (Gene bank accession
NM_001145295.1) in which exon 11 has been skipped, generating
a premature STOP codon that in turn shortens the peptide
sequence at its C-terminus. The missing region in this transcript
comprises most of the C-terminal domain that is required for the
binding of Ngly1p to N-linked oligosaccharides [39], suggesting that
these two NGLY1 gene products may not have equivalent
functions. Furthermore, inspection of the databases revealed the
presence of this minor NGLY1 transcript in the sequence data from
several mammals (Fig 4B). Next, the impact of these two NGLY1
gene products on fOS generation was examined. siRNA duplexes
targeting both common and distinctive regions of the transcripts
were designed (Table S1) and the ability of each to silence the two
transcripts was assessed by QPCR. Additionally, the ability of the
duplexes to block fOSGN2 generation was examined. In order to
simplify identification of efficient NGLY1-targeted RNAi duplexes,
fOS were examined in a background of Engase1p down regulation
where the majority of fOS occur as fOSGN2. Results shown in
Fig 4C demonstrate that among the three duplexes which cause
greater than 88% silencing of both transcripts, NGLY1-1 and
NGLY1-3 provoke a striking reduction in the generation of a
fOSGN2 migrating as Glc1Man9GlcNAc2, and a lesser reduction of
a fOSGN2 migrating as Man9GlcNAc2, whereas the fOSGN2
migrating as Man8GlcNAc2 appeared to be unaffected. The
fOSGN2 profiles obtained with NGLY1-1 and NGLY1-3, but not
NGLY1-2, were found to be identical to that obtained when the
ENG-3 transfected cells were pretreated with, and radiolabeled in
the presence of the PNGase inhibitor Z-vad-fmk (Z-vad) [40]
(Fig 4C). Although successful design of an effective duplex
specifically targeting the minor transcript was not achieved
(Fig 4C), one of the 3 duplexes targeting the major NGLY1
transcript selectively silenced this transcript without silencing the
minor transcript (NGLY1 Long-3). The fOS profile obtained with this
duplex was similar to those observed with Z-vad and NGLY1-1 and
NGLY1-3 duplexes, indicating that the major NGLY1 transcript
that encodes Ngly1p is responsible for the observed changes in fOS
generation in HepG2 cells (Fig 4C).
siRNA duplexes targeting NGLY1 inhibit the generation
of a pool of fOSGN2 comprising mainly Glc1Man9GlcNAc2
and Man9GlcNAc2
To gain more insight into fOS generation during Ngly1p down
regulation [2-
3H]glycoproteins and [2-
3H]fOS were examined
Table 1. The effects of MAN2C1- and ENGASE-targeted siRNA
duplexes on fOS steady state levels in HepG2 cells.
ENG-3 M2C1-1
Component (% in MBC
c) Fold Ctrl
a (% in MBC
b)
fOSGN2
d G1M9 11.1 -
e
M9 6.1 -
M8 7.0 -
fOSGN G1M9 1.2 6.3 (4.2)
M9 (7.4) 1.2 6.6 (6.3)
M8 (12.4) 1.0 5.1 (8.6)
M7 (10.4) 0.9 1.2 (10.2)
M6 (13.9) 0.5 (9.2) 0.4 (12.0)
M5 (12.6) 0.4 (10.7) 0.1 (5.7)
M4 (53.0) 0.4 (48.9) 0.1 (60.2)
M3 (.90) 0.4 (.90) 0.2 (.90)
aHepG2 cells were transfected with control and ENGASE (ENG-3)- and MAN2C1
(M2C1-1)-targetted RNAi duplexes prior to SLO permeabilisation to generate
cytosol and MBC fractions. After extraction, purification, derivatisation, fOS
were resolved by HPLC as described for Fig 3A and B.
bWhere peaks were clearly identified, the distribution of each component in the
cytosol and MBC fractions after permeabilisation with SLO was calculated as %
total component in MBC (% in MBC). Where this value is not shown, low levels
of material recovered from the MBC fraction did not permit unambiguous
detection of component.
cThe calculations described above
b were also performed for fOS identified in
cells transfected with the control siRNA duplex.
dfOSGN2 were quantitated by HPLC and fluorescence detection of total fOS-AP
before and after endoH treatment as described in Fig 3A. HPLC profiles
indicate the presence of at least two components migrating similarly to
Man8GlcNAc2-AP (Fig 3A, right panel) and these two components were
quantitated together. Small amounts of a component migrating as
Man7GlcNAc2-AP (Fig 3A, right panel) were also identified but were not
quantitated.
eTransfection of HepG2 cells with M2C1-1 provoked large accumulations of
fOSGN which masked the appearance of fOSGN2.
doi:10.1371/journal.pone.0011734.t001
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In this experiment, although Ngly1p down-regulation produced
the expected effect on the distribution of fOS (Fig 5A), the N-
glycan profile differed little from that derived from control cell
incubations (Fig 5B). It was noted that EndoH-released N-glycans
comprised 22.0%, 30.9% and 17.9% Glc1Man9GlcNAc, Man9-
GlcNAc and Man8GlcNAc, respectively, for the control RNAi-
transfected cells, and 22.8%, 32.2% and 15.6%, respectively, for
NGLY1-3 transfected cells. As the Ngly1p-dependent fOSGN2
pool is enriched in Glc1Man9GlcNAc2 whose N-linked counterpart
can interact with the lectins calnexin and calreticulin [2], we asked
whether or not formation of the Ngly1p-dependent fOSGN2 pool
required such N-glycan/lectin interactions. It is known that in
order for glycoproteins to interact with calnexin and calreticulin,
ER glucosidase-dependent trimming of triglucosylated N-glycans
must occur [4]. Accordingly, the effect of ER glucosidase
inhibition by castanospermine (CST) on Ngly1p-mediated fOS
generation was investigated. Fig 5C demonstrates the presence of
an Ngly1p-dependent pool of Glc3Man9GlcNAc2 and an Ngly1p-
independent pool of Glc3Man8GlcNAc2 during ER glucosidase
inhibition. In the same incubations it can be seen that the ratio of
N-linked Glc3Man9GlcNAc2 to Glc3Man8GlcNAc2 remains sim-
ilar under all the experimental conditions. Thus, an Ngly1p-
dependent fOS pool was detected in the absence of monogluco-
sylated N-glycans. Furthermore, irrespective of glucosidase inhibi-
tion, the Ngly1p-dependent fOS pools are predominantly fully
mannosylated whereas the Ngly1p-independent pools comprise
oligosaccharides containing mainly 8 residues of mannose.
Down regulation of Ngly1p leads to ,30% inhibition of
total fOS
Next the size of the Ngly1p-dependent fOS pool was calculated.
Accordingly, pulse-chase studies were performed in control RNAi-
,o rENG-3-transfected cells in which Ngly1p was either co-down
regulated with NGLY1-3, or inhibited with Z-vad. In 30 min pulse
radiolabeling incubations, Z-vad provokes about 25% total fOS
inhibition whereas Ngly1p down regulation leads to about 12%
fOS inhibition (Fig 6, Pulse, left panel). Down-regulation of
Engase1p alone did not provoke a significant inhibition of total
fOS, and comparing the Engase1p down regulation condition with
the Engase1p and Ngly1p compromised conditions, similar total
fOS inhibitions were noted (Fig 6, Pulse, left panel). In the latter
conditions, where quantitation of Man8GlcNAc2 is more mean-
ingful due to reduced fOSGN2-to-fOSGN conversion, substantial
inhibitions of the appearance of fOS migrating as Glc1Man9Glc-
NAc2 and Man9GlcNAc2 were noted whereas lesser inhibition of
Man8GlcNAc2 was observed (Fig 6, Pulse, right panel). Overall,
however, NGLY1-3-, or Z-vad-mediated fOS inhibitions were
similar irrespective of whether or not Engase1p was co-down
regulated. In cells that were pulse radiolabeled and chased for 1 h
(Fig 6, lower panels) the situation changed such that Engase1p
down regulation alone caused a small (5–10%) but significant
inhibition of total fOS generation (Fig 6, Chase, left panel). This
inhibition of the appearance of fOS mediated by Engase1p down
regulation alone was also reflected by increases in fOS inhibition
observed when both Engase1p and Ngly1p are compromised
compared to when the latter activity is reduced alone (Fig 6,
Figure 4. Alternative NGLY1 transcripts and the impact of their down regulation on fOS generation in HepG2 cells. A. Genomic
organization of the human NGLY1 gene and alternative transcripts found in HepG2 cells. The major transcript found in HepG2 cells is indicated in
blue and corresponds to the already published NGLY1 mRNA sequence (NM_018297.3). A minor transcript indicated in orange is generated by
skipping of exon 11 (NM_001145295.1). B. Partial alignment of homologous Ngly1p sequences (amino acids 522–558) encoded by the minor
transcript and comparison with the corresponding region of the major NGLY1 transcript (accession numbers: Macaca mulatta; XP_001092914, Equus
caballus; XP_001492093, Canis lupus familiaris; DN746692.1). Note that the isoform encoded by the minor transcript contains 21 amino acids in its
COOH terminal which are not found in the peptide sequence encoded by the major transcript. C. HepG2 cells were transiently transfected with the
different siRNA duplexes designed to silence either or both NGLY1 transcripts (see Table S1). Total RNA were extracted three days later and the mRNA
levels of each specific transcript were analyzed by QPCR. In parallel, HepG2 cells were co transfected with ENG-3 and the different siRNA duplexes
targeting the two NGLY1 transcripts. As described in Materials and Methods, because of the variable GC content of the different RNAi duplexes, two
negative control siRNA duplexes with either medium (med GC) or low GC (low GC) content were used. After 3 days cells were pulse-radiolabeled with
[2-
3H]mannose for 30 min. In some experiments, cells transfected with ENG-3 alone or with control RNAi duplexes were treated with either Z-vad-fmk
(40 mM) dissolved in DMSO (Z-vad*) or DMSO alone (*) for 45 min prior to, and during the radiolabeling period. Subsequently, [2-
3H]fOS, [2-
3H]LLO
and [2-
3H]Glycoproteins were extracted, purified and quantitated, and [2-
3H]fOS were analysed by TLC. In order to take into account the differences
in total incorporation of radiolabel into cells cultivated under the different conditions, a fraction of total fOS was loaded onto the TLC according to
the ratio of the total cellular radioactivity for a given incubation to that recovered from the incubation incorporating least radioactivity. The scanned
TLC lanes are from the same fluorograph, but due to uneven migration, the scans were aligned manually to facilitate interpretation of data. The
migration positions of standard oligosaccharides are shown to the left of the chromatograms and the abbreviations used are as described in Fig 1.
The percent inhibition of the major and minor NGLY1 transcripts provoked by the different RNAi duplexes was calculated using the QPCR data and is
indicated underneath the appropriate lanes. This experiment was performed once.
doi:10.1371/journal.pone.0011734.g004
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reduced, ,35% total fOS inhibition is noted in 1 h chase
incubations. In addition it can be seen that, in the presence of
ENG-3, the inhibitions of the appearance of fOS migrating as
Glc1Man9GlcNAc2 Man9GlcNAc2 and Man8GlcNAc2 caused by
Z-vad and NGLY1-3 were higher than those noted for the pulse
incubations (Fig 6, compare upper and lower right panels).
Although Z-vad and NGLY1-3 provoked small inhibitions of the
appearance of Man8GlcNAc2, this inhibition may be overestimat-
ed because of incomplete Engase1p down regulation leading to
contamination of this component with Glc1Man9GlcNAc and
Man9GlcNAc whose appearance is inhibited by Z-vad and
NGLY1-3. To summarise, taking into account that ENG-3 itself
causes a small but significant inhibition in the appearance of fOS,
it can be concluded that the Ngly1p-dependent fOS pool
corresponds to ,30% of total fOS.
Human Engase1p can generate fOS in Png1p-deficient
yeast
To further understand the potential physiological role of
Engase1p in glycoprotein deglycosylation, the capacity of this
enzyme to generate fOS in yeast was examined. Although S.
cerevisiae does possess cytosolic PNGase (Png1p, [20]) it does not
contain an Engase1p homolog and previous studies indicated that
fOSGN2 but not fOSGN are generated in this organism [21].
Accordingly, the S. cerevisiae Png1p null mutant (png1D) is a useful
strain with which to study the role of human Engase1p
(hEngase1p) in glycoprotein deglycosylation. Additionally, in order
to facilitate interpretation of results, the gene encoding the
vacuolar mannosidase, Ams1p, was deleted in the png1D strain
because it is known that this mannosidase degrades fOSGN2. In
fact, Ams1p expression is under glucose repression and the enzyme
is first synthesised in the cytosol before being translocated into the
vacuole [41]. Exponentially growing strains were harvested and
fOS were extracted, purified and derivatised with the fluorophore
2-AP. HPLC analysis of the resulting mixtures indicates that
whereas both the ams1D and ams1Dpng1D strains elaborate
fOSGN2 containing mainly 7 and 8 residues of mannose, there
is a ,50 fold reduction of these components in the latter strain
(Fig 7A, compare blue traces in upper and lower panels, and
Fig 7B). In yeast, an N-glycan bearing 7 residues of mannose [42]
that arises through the sequential actions of the mannosidases
Mns1p and Html1p [43] is thought to be involved in Yos9p-
targeting [42] of misfolded lumenal ER glycoproteins for
proteasomal degradation in the cytosol. These results are
reinforced by our previous findings demonstrating that whereas
the Man7GlcNAc2 N-glycan can not be detected in total
glycoprotein mixtures in the ams1D strain, the corresponding
fOSGN2 is relatively abundant [21]. Upon transfection of the
ams1D strain with Hist-tagged hEngase1p, about two thirds of total
fOS are now recovered as fOSGN (Fig 7A, red trace in upper
Figure 5. Examination of fOS, and N-glycans after NGLY1-3 or
Z-vad mediated reduction of Ngly1p activity in control and
castanospermine-treated cells. A. HepG2 cells were transfected
with 25 pmoles of control siRNA (Ctrl), or 25 pmoles of NGLY1-3. Three
days after transfection, cells were pulse-radiolabeled with [2-
3H]man-
nose for 30 min and cellular EndoH-released [2-
3H]N-glycans (N-glycans)
and [2-
3H]fOS (fOS) were prepared and analysed by HPLC. Whereas the
whole fOS fractions were analysed, only 25% of the N-glycan fractions
were examined by HPLC. The elution positions of standard oligosac-
charides are indicated above the HPLC profiles and the abbreviations
used are defined in the legend for Fig 2. B. HepG2 cells were transfected
with 50 pmoles of control siRNA (Ctrl), or 25 pmoles each of NGLY1-3
and 25 pmoles of control siRNA (NGLY), or 25 pmoles each of ENG-3 and
25 pmoles of control siRNA (ENG), or 25 pmoles each of NGLY1-3 and
ENG-3 (ENG + NGLY). Three days after transfection, cells were
preincubated for 30 min with 2 mM castanospermine (CST), and where
indicated, with 40 mM Z-vad-fmk (Z-vad). Cells were then pulse-
radiolabeled with [2-
3H]mannose for 30 min and cellular EndoH-
released [2-
3H]N-glycans (GP) and [2-
3H]fOS (fOS) were prepared and
examined by TLC. The scanned TLC lanes are from the same
fluorograph, but due to uneven migration, the scans were aligned
manually to facilitate interpretation of data. Closed and open
arrowheads indicate the migration positions of components bearing
one or two residues, respectively, of GlcNAc at their reducing end. The
abbreviations are: G3M9; Glc3Man9GlcNAc1-2,G 3M8; Glc3Man8GlcNAc1-2.
C. These experiments were performed once.
doi:10.1371/journal.pone.0011734.g005
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in the ams1D and ams1D
hENGASE strains are the same (Fig 7B).
Although total Man8GlcNAc1-2 generated in the ams1D
hENGASE
strain appears about 15% greater than that recovered from the
ams1D strain (Fig 7B) it is apparent that in the ams1D
hENGASE strain
the peak corresponding to Man8GlcNAc2 comprises several
species thereby causing an over estimation of total Man8-
GlcNAc1-2 in this strain. Nevertheless, despite the absence of
unambiguous evidence for a protein deglycosylating function of
hEngase1p in the ams1D strain, when the ams1Dpng1D strain
expresses hEngase1p, there is a clear generation of fOSGN species
containing 7 and 8 residues of mannose (Fig 7A, red trace in lower
panel) whose quantities represent ,20% of that of their Png1p-
generated fOSGN2 counterparts recovered from the ams1D strain
(Fig 7B). Several observations indicate that in the S. cerevisiae png1D
deletion mutant, hEngase1p can have a deglycosylating role
similar to that of Png1p. First, the HPLC profile of Png1p-
generated fOSGN2 observed in the ams1D strain (Fig 7A, blue trace
in upper panel) is similar to that of the Engase1p-generated fOSGN
generated in the ams1Dpng1D
hENGASE strain (Fig 7A, red trace in
lower panel). Second, N-glycans bearing 7 residues of mannose are
thought to be specific to misfolded glycoproteins that are translocated
from the ER into the cytosol. Third, subcellular fractionation studies
indicate that hEngase1p is located in the cytosol of transfected yeast
(Fig7C).Nevertheless,asEngase1pexpressionlevelsaresimilarinthe
ams1D
hENGASE and ams1Dpng1D
hENGASE strains (Fig 7A, inserts) it can
be concluded that, at least in a yeast background, hEngase1p is more
effective at converting fOSGN2 into fOSGN than generating
fOSGN from glycoproteins.
Discussion
The role of Engase1p in the conversion of fOSGN2 to
fOSGN
Although previous studies on the substrate specificity of the
cytosolic mannosidase (Man2c1p) demonstrated that its preferred
substrates are fOSGN [37], the gene product(s) required for
conversion of fOSGN2 into fOSGN in mammalian cells has not
been clearly identified. Here, we demonstrate in a mammalian cell
line that down regulation of ENGASE expression leads to: (i) a
block in the appearance of fOSGN; (ii) a slowdown of both the
disappearance of cytosolic fOSGN2 and the appearance of smaller
MBC-situated fOSGN (, Man7GlcNAc) during chase incuba-
tions; (iii) increased steady state levels of cytosolic fOSGN2, and
(iv) decreased steady state levels of several small cytosolic and
MBC-situated fOSGN (, Man5GlcNAc). Accordingly, several
lines of evidence demonstrate the importance of Engase1p in the
conversion of fOSGN2 into fOSGN. Although the ‘leakiness’ of
the block in fOSGN2 to fOSGN conversion observed in the
presently reported RNAi studies may be attributable to only 70%
down regulation of ENGASE mRNA, the possibility that, in
addition to Engase1p, another enzyme is involved in this process
cannot be excluded.
The role of Engase1p in the subcellular trafficking of fOS
Next, down regulation of Engase1p and Man2c1p was
undertaken in order to compare the roles of these two enzymes
on fOS trafficking in HepG2 cells. Oligosaccharide structures
recovered from different cellular compartments were examined
Figure 6. Quantitation of Ngly1p-dependent and -independent fOS pools in HepG2 cells. Cells were transfected with 50 pmoles of
control siRNA (Ctrl and Z-vad), or 25 pmoles each of NGLY1-3 and 25 pmoles of control siRNA (NGLY), or 25 pmoles each of ENG-3 and 25 pmoles of
control siRNA (ENG), or 25 pmoles each of NGLY1-3 and ENG-3 (ENG + NGLY). Three days after transfection, where indicated, cells were preincubated
for 30 min with 40 mM Z-vad-fmk (Z-vad). Cells were then pulse-radiolabeled in either the absence or presence of Z-vad with [2-
3H]mannose for
30 min (Pulse, left panels) or pulse-radiolabeled for 30 min prior to conducting a 1 h chase incubation (Chase, right panels). [2-
3H]lipid-linked
oligosaccharides, [2-
3H]N-glycans released by EndoH from both cellular and medium glycoproteins and [2-
3H]fOS were prepared and quantitated by
scintillation counting. After summing the radioactivity associated with the above described fractions to generate total radioactivity incorporation into
cells. [2-
3H]fOS were examined by TLC. In order to take into account the differences in total incorporation of radiolabel into cells cultivated under the
different conditions, the fraction of total fOS that was loaded onto the TLC was adjusted to take into account the ratio of the total cellular
radioactivity for a given incubation to that recovered from the incubation incorporating least radioactivity. The migration positions of standard
oligosaccharides are shown to the left of the chromatograms and the abbreviations used are as described in Fig 2. After elution of the
oligosaccharide components from TLC plates and quantitation by scintillation counting, inhibition of total fOS appearance with respect to the control
was calculated and is shown under the appropriate TLC lanes. The percentage inhibitions of individual oligosaccharides (Glc1Man9GlcNAc2:G 1M9,
Man9GlcNAc2:M 9, Man8GlcNAc2:M 8) observed in the ENG + NGLY and ENG + Z-vad conditions with respect to the ENG condition are shown to the
right of the chromatograms. The scanned TLC lanes are from the same fluorograph, but due to uneven migration, the scans were aligned manually to
facilitate interpretation of data. This experiment was repeated 4 times and the error bars represent the standard deviation.
doi:10.1371/journal.pone.0011734.g006
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state. The former studies performed in the presence of CCMA
revealed that both Engase1p and Man2c1p are required for the
efficient translocation of cytosolic fOS into MBC. Furthermore, it
is demonstrated that both Engase1p and Man2c1p regulate fOS
steady state levels in both the cytosol and MBC compartments of
SLO-permeabilised HepG2 cells. HPLC profiles of the steady state
levels of cytosolic fOS reported herein are similar to those reported
for the cytosol of HepG2 cells [38]. Importantly, we show that as
well as provoking an accumulation of large fOSGN, Man2c1p
down-regulation causes a 90% reduction of the steady state level of
linear Man5GlcNAc, one of the terminal digest products of
Man2c1p. Accordingly, contrary to that seen in HEK-293 cells
[17], the bulk of linear Man5GlcNAc is generated by Man2c1p in
HepG2 cells. Engase1p down-regulation also reduces the steady
state level of linear Man5GlcNAc, but this reduction is lesser in
magnitude probably as the accumulations of fOSGN2 observed
under these conditions are less pronounced than the accumula-
tions of large fOSGN provoked by Man2c1p down-regulation.
Reductions in total Man5GlcNAc steady state levels by either
Engase1p or Man2c1p down-regulation are accompanied by
reductions in Man4-3GlcNAc recovered predominantly from
the MBC. The peaks co migrating as standard Man4-
GlcNAc, Man5GlcNAc and Man6GlcNAc (containing mainly
Glc1Man5GlcNAc) are known to correspond to the limit digest
products of Man2c1p action on different cytosolic polymannose
structures in which the a1,3-, or A branch, is either missing its
terminal mannose, intact, or is substituted with glucose, respec-
tively [38]. The absence of the Man3GlcNAc structure in the
cytosolic compartment along with its reduction in the MBC of
M2C1-1 and ENG-3 transfected cells suggests that this structure
originates from lysosomal trimming of cytosol-derived Man4-
GlcNAc and Man5GlcNAc after transport into lysosomes.
Although these results agree well with the previously described
biochemical characteristics of the lysosomal fOS transporter which
is specific for partially demannosylated oligosaccharidic structures
[12], it was consistently noted during pulse-chase studies
performed in the absence or presence of CCMA that this reagent
Figure 7. Examination of the deglycosylating role of human
Engase1p in Png1p-deficient yeast cells. A. Obtention of the S.
cerevisiae ams1D and ams1Dpng1D strains, deficient in the vacuolar
mannosidase, Ams1p, and their transfection with an empty vector or a
vector encoding Hist-tagged human Engase1p, is described in Materials
and Methods. Cells were grown to mid log phase and fOS were
extracted, purified and derivatised with 2-AP. Derivatised fOS (corre-
sponding to 146, 92, 166 and 88 DU600 nm for the ams1D, ams1D
hENGASE,
ams1Dpng1D and ams1Dpng1D
hENGASE strains, respectively) were
resolved by HPLC and detected using an on line fluorescence detector.
Arrows indicate the elution times of fOS containing either a single (1) or
two (2) residues of N-acetylglucosamine at their reducing termini.
Insets. The ams1D (upper panel) and ams1Dpng1D (lower panel) strains
transfected with the empty vector (2 hEngase1p) or the vector
encoding Hist-tagged human Engase1p (+ hEngase1p) were grown to
mid log phase and cell extracts were probed with an anti Hist tag
antibody after SDS PAGE by Western blot. Hist-tagged hEngase1p (*)
has a molecular mass of 80 kDa. The migration position of 100 and
75 kDa markers are indicated to the left of the blots. B. After correction
for the different quantities of starting material used for each yeast strain
the areas under the HPLC peaks corresponding to Man7GlcNAc2 and
Man7GlcNAc (M7GN1-2) were summed, as were those for Man8GlcNAc2
and Man8GlcNAc (M8GN1-2). C. Wild type cells were transfected with the
vector encoding Hist-tagged human Engase1p, grown to mid log
phase, converted into spheroplasts, and permeabilised as described in
Materials and Methods. After centrifugation, cytosol and membrane
fractions were assayed for Engase1p (ENG), cytosolic a-glucosidase
(aGlc) and vacuolar carboxypeptidase Y (CPY) activities which have
been expressed as a percentage of the sum of the cytosol and
membrane values. This experiment was performed once.
doi:10.1371/journal.pone.0011734.g007
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but also caused less striking but clear MBC accumulations of larger
fOS (See Fig 2B and C; compare upper and lower panels) known
to be poor substrates for the lysosomal fOS transporter. Whether
or not these larger structures are slowly transported into lysosomes
remains to be established, but the use of 3-methyladenine, a well
known inhibitor of autophagic sequestration, indicates that these
structures may not be sequestered into the endomembrane system
by the classical autophagy-lysosomal pathway (Chantret, I. and
Moore, S. unpublished observations).
Engase1p and Man2c1p are required for externalization
of fOS in CCMA-treated HepG2 cells
We previously published that a small fraction of fOS can be
found in the medium of CCMA-treated HepG2 cells [11]. Here, it
is shown that when compared to intracellular cytosolic- or MBC-
situated fOS species, the extracellular pool is enriched in smaller
components indicating that either fOS are degraded in the
medium or the externalization process is selective towards smaller
components. Since the externalization process is not inhibited by
BFA (data not shown), it is distinct from the classical Golgi
apparatus-dependent secretion pathway. CCMA inhibits the
vacuolar ATPase and perturbs vesicular trafficking including
endosomal transport [44]. As well as modifying the intracellular
distribution of lysosomal b-hexosaminidase [11], observations
indicate that CCMA also causes a BFA-independent appearance
of lysosomal b-hexosaminidase in the culture medium without
accompanying cell damage as assessed by extracellular LDH levels
(Chantret, I. and Moore, S. unpublished observations). In the light
of these results, it can be hypothesised that perturbation/fusion of
elements of the lysosome/endosome system allows secretion of
lysosomal contents into the extracellular space. Whatever the
mechanism underlying the appearance of fOS in the extracellular
space of CCMA-treated HepG2 cells both Engase1p and
Man2c1p are required for this process.
Does Engase1p deglycosylate glycoproteins under
physiological conditions?
This has proved a difficult question to answer. In a C. elegans
ENGASE null mutant, an accumulation of fOSGN2 was noted to
accompanyanetreductionoftotalfOS[45].Thisphenomenonwas
interpreted to be a consequence of inhibition of Ngly1p by high
levels of fOSGN2 [46]. Here, we were unable to demonstrate an
inhibition of the appearance of fOS in pulse-radiolabeled Engase1p
compromisedcells,butexaminationoffOSin1 hchaseincubations
revealed a 5–10% inhibition of fOS mediated by Engase1p down
regulation. It is unlikely that these results are due to inhibition of
Ngly1p by fOSGN2, as the 6–11 fold increases of fOSGN2 steady
state levels observed (Fig 3A and Table 1) are not likely to change
between the pulse and chase periods. As this enzyme is more active
toward fOS and glycopeptides than glycoproteins [27] it perhaps
plays a role in the deglycosylation of a small pool of glycoproteins/
glycopeptides after the bulk of fOS have been generated by other
mechanisms. A deglycosylating role for Engase1p is reinforced by
our demonstration that, in vivo, hEngase1p can liberate fOSGN in
the S.cerevisiae ams1Dpng1D strain. Finally, glycoproteins that have
been deglycosylated by an ENGase activity will possess residual N-
linked GlcNAc residues, and in fact just such glycoproteins have
recently been identified in cultured cells but at present it is not clear
whether or not they were deglycosylated by an ENGase activity
[47]. Accordingly, the importance of Engase1p in glycoprotein/
glycopeptide deglycosylation under normal physiological conditions
remains to be determined. Furthermore, under certain conditions of
ER or cellular stress the deglycosylating roles Ngly1p and Engase1p
may change.
The role of Ngly1p in the generation of fOSGN2
In this study, we demonstrated the presence of a minor short
NGLY1 transcript potentially encoding a C-terminally truncated
protein. This transcript wasidentified in Caco 2 cellsand inprimary
fibroblast cultures (Chantret, I. and Moore, S. unpublished
observations) as well as HepG2 cells. Whether or not a protein is
encoded by this short transcript remains to be established, but our
results suggest that it is not involved in fOS generation. By contrast,
our data clearly demonstrate a role for the major, full length,
NGLY1 transcript in the generation of a limited pool of fOSGN2
that is enriched in Glc1Man9GlcNAc2 and Man9GlcNAc2 when
compared to the total fOS pool. This relatively restricted role of
Ngly1p on fOS generation in HepG2 cells was unexpected in view
of previous work conducted on S. cerevisiae where Png1p, the yeast
Ngly1p ortholog, is responsible for the generation of greater than
70% of all fOS in yeast [21]: see also Fig 7A and B where steady
state fOS levels in the ams1Dpng1D strain are about 2% of that
occurring in the ams1D strain. Any explanation of this weak effect of
NGLY1 mRNA down regulation must take into account the fact
that the PNGase inhibitor Z-vad-fmk yields the same result.
Differences have also been observed between yeast and mammalian
cells concerning the role of Ngly1p during degradation of ERAD
substrates. Indeed, in the png1D strain an important slowing down
or a total block of the degradation of ERAD substrates like CPY*
[20] or ricin A [48] is observed. By contrast, studies in mammalian
cells have favored a less important role of Ngly1p during ERAD.
Thus, down-regulation of NGLY1 in cells stably transfected with
siRNA duplexes [49] or with the use of Z-vad-fmk [40], did not
dramatically modify the degradation rate of different misfolded
glycoproteins which were known to be ERAD substrates. These
data combined with results from this study, reinforce the idea that
while Png1p plays a crucial role in the degradation of misfolded
glycoproteins in yeast, the presence of an Engase1p in mammalian
cells may allow deglycosylation of some glycoproteins and
subsequent proteasomal degradation in the absence of Ngly1p.
The extent of the Ngly1p-dependent pool has been difficult to
determine, but a 30–40% inhibition of total fOS was obtained after
1h of chase when Ngly1p was co-down regulated with Engase1p.
When Engase1p is down regulated it was noted that the Ngly1p-
generated fOSGN2 pool comprised mainly Glc1Man9GlcNAc2 and
Man9GlcNAc2 structures whereas the Ngly1p-independent pool
comprised mainly Man8GlcNAc2. Likewise, when ER glucosidases
are inhibited, Ngly1p down-regulation inhibited Glc3Man9Glc-
NAc2 generation whereas Glc3Man8GlcNAc2 generation was
unaffected. The paucity of Man8GlcNAc2 structures in the
Ngly1p-dependent fOS pool is intriguing as some ERAD pathways
are thought to involve mannose trimming of the N-glycans of
misfolded glycoproteins [50]. Whether or not these pathways are
extensively solicited in unstressed mammalian cells is unknown.
Perhaps the untrimmed nature of the Ngly1p-dependent fOSGN2
observed in this study (Glc1-3Man9GlcNAc2) reflects an early
cotranslational pre-emptive ERAD mechanism thought to be able
to clear proteins that are blocked in the transclocon [51]. Although
it is not clear which if any of the presently described ERAD
processes could be at the origin of the Ngly1p-generated
oligosaccharide pool(s) observed in our study, the predominantly
fully mannosylated status of these fOS differentiates them from the
Ngly1p-independent fOSGN2 containing 8 residues of mannose.
Some observations suggest that this latter fOS pool may originate
from LLO: first, at present Ngly1p and Engase1p are the only two
enzymes known to generate fOS from glycoproteins; second, in vitro
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of the ER are rapidly processed to Man8GlcNAc2 before transport
intothe cytosol [10]. If LLO hydrolysis is the major source of fOS in
normally cultured mammalian cells, the question that leads on from
these results is: are fOS generated merely as a byproduct of LLO
regulation or do they have some function in the cell as has been
proposed for these structures in Campylobacter jejuni [52]?
To conclude, we describe Ngly1p-dependent and -independent
fOSGN2 pools. Engase1p is able to release fOSGN from
glycoproteins in png1D yeast strains, and some evidence is
presented to indicate that it may have a deglycosylating role in
HepG2 cells. We demonstrate that conversion of fOSGN2 to
fOSGN, the first comitted step in the clearance of cytosolic fOS
into lysosomes, is mediated by Engase1p. Finally, we demonstrate
that in HepG2 cells the bulk of fOS are not generated by either
Ngly1p or Engase1p suggesting the presence of other protein
deglycosylating enzymes or substantial generation of fOS from
LLO. The mechanisms underlying the generation of the various
fOS pools in mammalian cells certainly merit further study
because they reflect key control processes during protein N-
glycosylation, quality control and ERAD.
Supporting Information
Table S1 Primers used in this study
Found at: doi:10.1371/journal.pone.0011734.s001 (0.03 MB
XLS)
Figure S1 Inhibition of ENG1 gene expression induced by
siRNA in HepG2 cells - Cells were transiently transfected with 1,
10 and 100 pmoles of either negative control RNAi duplexes or 3
sets of ENG1 RNAi duplexes (ENG-1, ENG-2 and ENG-3). Total
mRNA were extracted 3 days later and ENGASE mRNA levels
were quantitated by QPCR as described in Material and Methods.
Found at: doi:10.1371/journal.pone.0011734.s002 (2.88 MB
TIF)
Figure S2 Effects of the inhibition of Man2C1 gene expression
on fOS metabolism - (A) Kinetics of inhibition of Man2C1
transcripts by 3 siRNA duplexes. HepG2 cells were transiently
transfected with 25 pmoles of 3 different short interfering RNA
sequences (M2C1-1, M2C1-2 and M2C1-3) targetting the
cytosolic Man2C1 mannosidase. 1, 2 and 3 days post-transfection,
cDNA was prepared. Quantitative PCR was used to estimate
changes in mRNA levels of the Golgi Man2A1, lysosomal
Man2B1 and cytosolic Man2C1 mannosidases relative to those
observed in cells transfected with a control interfering RNA
sequence. (B) Cells were transfected with either negative control
RNAi duplexes (Ctrl) or Man2C1 RNAi duplexes (M2C1-1,
M2C1-2 and M2C1-3) 2 days before pulse-radiolabeling with [2-
3H]mannose for 30 min. Subsequent to pulse or 4 h of chase
incubations, fOS were extracted from cells and chase media as
described in Material and Methods. Purified fOS were then
resolved by thin layer chromatography on silica-coated plates. The
migration positions of standard oligosaccharides are shown to the
left of the chromatographs and the abbreviations associated with
the open arrowheads are: G1M9, Glc1Man9GlcNAc2 ; M9,
Man9GlcNAc2 and M8, Man8GlcNAc2. Those associated with
the closed arrowheads are: G1M9, GlcMan9GlcNAc; M9,
Man9GlcNAc; M8, Man8GlcNAc; M7, Man7GlcNAc; M6,
Man6GlcNAc; G1M5, GlcMan5GlcNAc; and M5, Man5GlcNAc.
(C) Negative control RNAi duplexes (Ctrl) or RNAi duplexes
targeting Man2c1 (M2C1-1, M2C1-2 and M2C1-3) transfected
cells were pulse-radiolabeled with [2-3H]mannose, and where
indicated, were pretreated with 100 mM swainsonine (Ctrl+SW).
Subsequent to performing 6 h chase incubations in either the
presence or absence of SW, glycopeptides were prepared from
both cells and media. Con A-Sepharose affinity chromatography
was used to quantitate complex-, hybrid- and polymannose-type
glycopeptides as described in Materials and Methods section. SW
was used as a positive control in order to verify that the Con A-
Sepharose affinity chromatography was able to detect changes in
protein glycosylation induced by inhibiting Golgi mannosidase II.
Found at: doi:10.1371/journal.pone.0011734.s003 (9.55 MB
TIF)
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